The Scandinavian Simvastatin (the active ingredient contained in Zocor) Survival Study (4S) demonstrated a 30% reduction in total mortality in patients followed for a median of 5.4 years and a 42% decrease in death from coronary heart disease compared to placebo. Simvastatin reduced the risk of major coronary events by 34%, hospital verified nonfatal myocardial infarction by 37%, and the need for coronary artery bypass graft or angioplasty by 37%, all significant compared to placebo.
I suggest you contact your Cardiologist asap, as increased heart beat is not listed as a possible side effect, nor has it been reportedas of now.
- Zocor Information for Consumers
- Zocor Information for Healthcare Professionals (includes dosage details)
- Side Effects of Zocor (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 27 Oct 2011 • 1 answer
Posted 30 Dec 2011 • 1 answer
Posted 18 May 2013 • 1 answer
Posted 16 Oct 2015 • 0 answers
Posted 29 Apr 2017 • 0 answers